UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 39

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

Journal of thrombosis and haemostasis, 2003-03, Vol.1 (3), p.450-455

2003

Volltextzugriff (PDF)

Protein disulfide isomerase mediates integrin-dependent adhesion

FEBS letters, 2000-06, Vol.475 (2), p.89-92

2000

Volltextzugriff (PDF)

Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis

American journal of roentgenology (1976), 2003-03, Vol.180 (3), p.729-732

2003

Volltextzugriff (PDF)

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.625-629

2011

Volltextzugriff (PDF)

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-09, Vol.15 (5), p.1065-1073

2009

Volltextzugriff (PDF)

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.676-685

2009

Volltextzugriff (PDF)

Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-09, Vol.14 (5), p.1122-1124

2008

Volltextzugriff (PDF)

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (4), p.372-379

2006

Volltextzugriff (PDF)

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-11, Vol.13 (6), p.722-729

2007

Volltextzugriff (PDF)

P033: From thrombasthenia to next generation thrombocytopenia: neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia

Thrombosis research, 2019-03, Vol.175, p.S18-S18

2019

Volltextzugriff (PDF)

Hepatitis C at the Israeli National Hemophilia Center

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-01, Vol.12 (1), p.68-74

2006

Volltextzugriff (PDF)

Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.806-809

2001

Volltextzugriff (PDF)

Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange

Blood, 2002-10, Vol.100 (7), p.2472-2478

2002

Volltextzugriff (PDF)

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma

Canadian journal of anesthesia, 2002-12, Vol.49 (10), p.S15-S20

2002

Volltextzugriff (PDF)

Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma

The journal of trauma, 2001-09, Vol.51 (3), p.431-439

2001

Volltextzugriff (PDF)

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

Blood coagulation & fibrinolysis, 2000-04, Vol.11 Suppl 1, p.S35-S38

2000

Volltextzugriff (PDF)

Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-09, Vol.8 (5), p.622-628

2002

Volltextzugriff (PDF)

Significance of BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients

Leukemia & lymphoma, 1999-03, Vol.33 (1-2), p.77-82

1999

Volltextzugriff (PDF)

Cutaneous necrosis as a terminal paraneoplastic thromboembolic event in a patient with non‐Hodgkin’s lymphoma

Journal of internal medicine, 1999-03, Vol.245 (3), p.301-305

1999

Volltextzugriff (PDF)

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study: EARLY EXPOSURE TO RECOMBINANT FACTOR INCREASE INHIBITOR DEVELOPMENT

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.625-629

2011

Volltextzugriff (PDF)

A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1167-1175

2004

Volltextzugriff (PDF)

A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1167-1175

2004

Volltextzugriff (PDF)

The Management of Giant Haemophilic Pseudotumours

Musculoskeletal Aspects of Haemophilia, 2000, p.105-111

2000

Volltextzugriff (PDF)

BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients: Clinical Presentation

Blood, 1997-10, Vol.90 (7), p.2768-2771

1997

Volltextzugriff (PDF)

Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere

Thyroid (New York, N.Y.), 1999-10, Vol.9 (10), p.1033

1999

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(37)
Hebräisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Science & Technology
(28)
Life Sciences & Biomedicine
(27)
Male
(22)
Adult
(20)
Female
(17)
Hematology
(16)
Middle Aged
(16)
Aged
(12)
Biological And Medical Sciences
(8)
Hemophilia A - Drug Therapy
(6)
Medical Sciences
(6)
Adolescent
(5)
Hematologic And Hematopoietic Diseases
(5)
Surgery
(5)
Child
(4)
Drug Administration Schedule
(4)
Factor Viii - Pharmacokinetics
(4)
Haemophilia
(4)
Hemorrhage - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

Protein disulfide isomerase mediates integrin-dependent adhesion

Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients

P033: From thrombasthenia to next generation thrombocytopenia: neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia

Hepatitis C at the Israeli National Hemophilia Center

Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome

Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma

Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience

Significance of BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients

Cutaneous necrosis as a terminal paraneoplastic thromboembolic event in a patient with non‐Hodgkin’s lymphoma

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study: EARLY EXPOSURE TO RECOMBINANT FACTOR INCREASE INHIBITOR DEVELOPMENT

A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation

A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation

The Management of Giant Haemophilic Pseudotumours

BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients: Clinical Presentation

Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere

Suchergebnisse filtern